Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial

NCT05322252 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT05322252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05322252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial
Lead sponsor
Washington University School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2022
Completion date
July 14, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abortion, second trimester, fetal death, fetal death before 22 weeks with retention of dead fetus, fetal demise, fetal demise from miscarriage, pprom, pregnancy complications, pregnancy loss, rupture, spontaneous